Pending AI is a leading brand that specializes in providing AI solutions for scientists in the pharmaceutical industry. Their goal is to accelerate the process of drug discovery and treatment for various diseases. With an emphasis on designing, making, and testing new drugs, Pending AI offers a range of innovative and data-driven products and services.

Their AI models are trained on massive federated datasets, consisting of millions of data points, to offer high-quality evidence-based solutions. By augmenting the cognitive abilities of individual scientists and teams, AI-based solutions enable them to make more informed decisions in drug design. Pending AI offers a set of complementary solutions to accelerate drug discovery, including de novo drug design, structure-based drug design, high-throughput chemistry, and synthesis planning.

These solutions leverage the power of AI to generate novel molecules, dock virtual molecules to proteins, streamline experimentation, and design optimal synthetic routes. Joining forces with Pending AI means embracing cutting-edge advancements in scientific innovation. Contact them today to explore new possibilities in the world of pharmaceutical research and development